The global cervical disc prosthesis market size was estimated at around USD 253 million in 2021 and it is projected to hit around USD 0.85 billion by 2030, growing at a CAGR of 14.41% from 2022 to 2030.
Report Highlights
Key factors driving the market growth include the rising prevalence of degenerative disc disease and the growing demand for minimally-invasive procedures. More back and neck disorders can now be addressed with a minimally invasive surgical procedure due to technical advancements in recent years. Because Minimally Invasive Spine Surgery (MISS) does not require a big incision, it reduces the risk of major injury to the muscles surrounding the spine and allows the doctor to see only the area of the spine where the problem arises.
Owing to these approaches, such as using fewer devices, the surgical field (also known as exposure) is smaller, resulting in less pain and a speedier recovery. These factors are expected to drive the overall market. The cervical disc prosthesis business decreased as a result of the COVID-19 pandemic, notably in 2020. All elective surgeries, including spine surgery, were postponed between March 17 and June 8, 2020, and hospitals were transformed into recognized COVID-19 treatment facilities. As a result, such variables have a detrimental impact on market growth. Many emerging nations’ healthcare reforms are extending treatment access to a larger proportion of their people, which is expected to stimulate the demand for healthcare-related items, particularly spinal surgery products.
Increasing economic affluence in major developing regions would boost the demand for such products, resulting in market expansion. Due to the growing geriatric population and greater success rate for cervical disc replacements, North America is anticipated to account for a sizable portion of the market. In the U.S., almost 80 million adults have lower back pain at some point in their lives, according to the National Institute of Neurological Disorders and Stroke. One of the most frequent excuses for missing work in the U.S. is back pain. Every year, back pain symptoms are reported by 50% of Americans who are employed. A significant portion of the expansion of the regional market as a whole is also being driven by the rising healthcare spending and the presence of established healthcare infrastructure.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 253 million |
Revenue Forecast by 2030 | USD 0.85 billion |
Growth rate from 2022 to 2030 | CAGR of 14.41% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Disc type, material type, indication, end-use, region |
Companies Covered | Medtronic; Depuy Synthes (Johnson & Johnson Inc.); Stryker Corp.; Zimmer Biomet Holdings, Inc.; Globus Medical, Inc.; NuVasive, Inc.; Orthofix Medical Inc.; Olympus Corp.; Centinel Spine, Inc.; Axiomed Spine Corp. |
Disc Type Insights
Based on disc types, the global market for cervical disc prosthesis has been further divided into Metal-On-Polymer (M-o-P) and Metal on Metal (M-o-M). The M-o-P disc type segment dominated the global market in 2021 and accounted for the maximum share of more than 65.07% of the overall revenue. As a bearing surface for many joints, metal-on-polymer articulations have substantial clinical experience and literature backing. The majority of FDA-approved cervical TDR implants in the U.S. use repetitions of metal alloy-based superior & inferior prosthetic endplates that articulate through a central polymer core.
Furthermore, the overall success rate of metal-polymer artificial disc replacement operations is high, boosting the market growth. Furthermore, the market is predicted to develop on account of an increase in the number of trauma-related and sports-related injuries, as well as orthopedic operations. Approximately 1.2 million football-related injuries occur each year, according to the NFL Physicians Society. The market is also expected to expand as a result of global technological improvements and a growing elderly population. However, the M-o-M disc type segment is estimated to witness the fastest CAGR from 2022 to 2030.
Material Insights
Based on materials, the global market has been further sub-segmented into stainless steel, cobalt-chromium, titanium, and others. The cobalt material segment dominated the global market in 2021 and accounted for the largest share of more than 35.56% of the global revenue. With high specific strength and stiffness that is nearly twice that of titanium, Cobalt Chromium-chrome (CoCr) is a Cobalt Chromium-chromium metal alloy. It is frequently referred to as Cobalt Chromium-chromium-Molybdenum (CoCrMo) since the alloy used to create surgical implantation prosthesis typically contains 5-7% molybdenum.
Due to their excellent biocompatibility and corrosion resistance, CoCr alloys have little danger of irritability, allergic reaction, or immunological response, which is expected to propel the growth of this segment. Stainless steel has long been utilized as surgical implants in numerous orthopedic applications, however, because of its inferior mechanical qualities, it may not always be recommended in cervical arthroplasties. Innovative metals, such as CoCr alloy and Titanium (Ti), have higher yield strengths and are less prone to corrosion and fatigue failure than older metals.
End-use Insights
Based on end-uses, the global market has been further categorized into hospitals, orthopedic & trauma centers, and others. The hospitals end-use segment dominated the global market in 2021 and accounted for the largest share of more than 44.12% of the overall revenue. The segment growth can be attributed to the fact that most facilities and technologically advanced implants are available in hospital settings for the treatment and diagnosis of cervical spine disorders. The growing demand for prostheses for patients suffering from myelopathy, radiculopathy, and severe neck pain is another factor propelling the growth of the segment during the forecast period.
On the other hand, the orthopedics and trauma centers' end-use segment is estimated to register the fastest growth rate during the forecast period. Orthopedics and trauma centers provide end-to-end care and management for all types of bone and joint disorders. Many patients experience less pain in their daily activities as a result of the professional and individualized surgical approach to bone and joint disorders offered at these centers. Furthermore, surgeons in these centers are highly specialized and experienced with cutting-edge research to provide the best possible care.
Regional Insights
On the basis of geographies, the global market has been further categorized into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominated the global market and accounted for the largest share of more than 48.84% of the global revenue in 2021. The high share of this regional market can beattributed to the presence of several key service providers along with their adoption of various strategic initiatives to increase market penetration. Furthermore, the presence of a technologically advanced population base and various initiatives undertaken by the government and the American Health Information Community will also boost the market growth.
The regional market of Asia Pacific is estimated to register the fastest growth rate during the forecast period. The increasing geriatric population pool is one of the dominant factors driving the growth of the Asia Pacific regional market. Constant improvements in the quality of life and total life expectancy, attributed to the developments in health care facilities and rising disposable income levels, also support market growth. The geriatric population pool makes up a sizable portion of the sub-population that is vulnerable to several diseases and disorders, including degenerative spine diseases, which, in turn, augments the product demand.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cervical Disc Prosthesis Market
5.1. COVID-19 Landscape: Cervical Disc Prosthesis Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cervical Disc Prosthesis Market, By Disc Type
8.1. Cervical Disc Prosthesis Market, by Disc Type, 2022-2030
8.1.1. Metal-On-Polymer (M-o-P)
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Metal on Metal (M-o-M)
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cervical Disc Prosthesis Market, By Indication
9.1. Cervical Disc Prosthesis Market, by Indication e, 2022-2030
9.1.1. Myelopathy
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Radiculopathy
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Neck Pain
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cervical Disc Prosthesis Market, By Material
10.1. Cervical Disc Prosthesis Market, by Material, 2022-2030
10.1.1. Stainless Steel
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Cobalt Chromium
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Titanium
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cervical Disc Prosthesis Market, By End-use
11.1. Cervical Disc Prosthesis Market, by End-use, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Orthopedic and Trauma Centers
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cervical Disc Prosthesis Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Indication (2017-2030)
12.1.3. Market Revenue and Forecast, by Material (2017-2030)
12.1.4. Market Revenue and Forecast, by End-use (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Indication (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Material (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Indication (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Material (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Indication (2017-2030)
12.2.3. Market Revenue and Forecast, by Material (2017-2030)
12.2.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Indication (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Material (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Indication (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Material (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Indication (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Material (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Indication (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Material (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Indication (2017-2030)
12.3.3. Market Revenue and Forecast, by Material (2017-2030)
12.3.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Indication (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Material (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Indication (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Material (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Indication (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Material (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Indication (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Material (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Indication (2017-2030)
12.4.3. Market Revenue and Forecast, by Material (2017-2030)
12.4.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Indication (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Material (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Indication (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Material (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Indication (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Material (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Indication (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Material (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Indication (2017-2030)
12.5.3. Market Revenue and Forecast, by Material (2017-2030)
12.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Indication (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Material (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Disc Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Indication (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Material (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 13. Company Profiles
13.1. Medtronic, Plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Depuy Synthes (Johnson & Johnson Inc.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Stryker Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Zimmer Biomet Holdings, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Globus Medical, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. NuVasive, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Orthofix Medical Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Olympus Corp.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Centinel Spine, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Axiomed Spine Corp.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms